Logo image of SCHA.OL

SCHIBSTED ASA-CL A (SCHA.OL) Stock Fundamental Analysis

Europe - OSL:SCHA - NO0003028904 - Common Stock

340 NOK
+1.4 (+0.41%)
Last: 5/12/2025, 4:19:51 PM
Fundamental Rating

5

Overall SCHA gets a fundamental rating of 5 out of 10. We evaluated SCHA against 62 industry peers in the Media industry. While SCHA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SCHA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SCHA had positive earnings in the past year.
In the past year SCHA had a positive cash flow from operations.
SCHA had positive earnings in 4 of the past 5 years.
Each year in the past 5 years SCHA had a positive operating cash flow.
SCHA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCHA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

With an excellent Return On Assets value of 32.31%, SCHA belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
SCHA's Return On Equity of 39.89% is amongst the best of the industry. SCHA outperforms 92.65% of its industry peers.
SCHA's Return On Invested Capital of 2.09% is on the low side compared to the rest of the industry. SCHA is outperformed by 69.12% of its industry peers.
SCHA had an Average Return On Invested Capital over the past 3 years of 2.06%. This is significantly below the industry average of 8.09%.
The 3 year average ROIC (2.06%) for SCHA is below the current ROIC(2.09%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 32.31%
ROE 39.89%
ROIC 2.09%
ROA(3y)1.92%
ROA(5y)14.39%
ROE(3y)-1.98%
ROE(5y)16.93%
ROIC(3y)2.06%
ROIC(5y)2.64%
SCHA.OL Yearly ROA, ROE, ROICSCHA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

The Profit Margin of SCHA (155.64%) is better than 97.06% of its industry peers.
SCHA's Profit Margin has improved in the last couple of years.
SCHA's Operating Margin of 12.17% is fine compared to the rest of the industry. SCHA outperforms 77.94% of its industry peers.
In the last couple of years the Operating Margin of SCHA has declined.
Looking at the Gross Margin, with a value of 111.90%, SCHA belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
SCHA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.17%
PM (TTM) 155.64%
GM 111.9%
OM growth 3Y-1.54%
OM growth 5Y-3.72%
PM growth 3Y-18.04%
PM growth 5Y99.1%
GM growth 3Y-1.25%
GM growth 5Y-1.05%
SCHA.OL Yearly Profit, Operating, Gross MarginsSCHA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SCHA is destroying value.
The number of shares outstanding for SCHA has been increased compared to 1 year ago.
SCHA has less shares outstanding than it did 5 years ago.
SCHA has a better debt/assets ratio than last year.
SCHA.OL Yearly Shares OutstandingSCHA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SCHA.OL Yearly Total Debt VS Total AssetsSCHA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

SCHA has a debt to FCF ratio of 5.81. This is a neutral value as SCHA would need 5.81 years to pay back of all of its debts.
SCHA has a Debt to FCF ratio (5.81) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.11 indicates that SCHA is not too dependend on debt financing.
The Debt to Equity ratio of SCHA (0.11) is better than 79.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 5.81
Altman-Z N/A
ROIC/WACC0.25
WACC8.22%
SCHA.OL Yearly LT Debt VS Equity VS FCFSCHA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

SCHA has a Current Ratio of 3.04. This indicates that SCHA is financially healthy and has no problem in meeting its short term obligations.
SCHA has a better Current ratio (3.04) than 95.59% of its industry peers.
A Quick Ratio of 3.04 indicates that SCHA has no problem at all paying its short term obligations.
SCHA has a Quick ratio of 3.04. This is amongst the best in the industry. SCHA outperforms 95.59% of its industry peers.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 3.04
SCHA.OL Yearly Current Assets VS Current LiabilitesSCHA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 365.92% over the past year.
Measured over the past years, SCHA shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.81% on average per year.
Looking at the last year, SCHA shows a quite strong growth in Revenue. The Revenue has grown by 9.29% in the last year.
Measured over the past years, SCHA shows a very negative growth in Revenue. The Revenue has been decreasing by -15.28% on average per year.
EPS 1Y (TTM)365.92%
EPS 3Y75.21%
EPS 5Y33.81%
EPS Q2Q%-120.87%
Revenue 1Y (TTM)9.29%
Revenue growth 3Y-17.12%
Revenue growth 5Y-15.28%
Sales Q2Q%-46.89%

3.2 Future

The Earnings Per Share is expected to decrease by -26.48% on average over the next years. This is quite bad
The Revenue is expected to grow by 3.20% on average over the next years.
EPS Next Y-81.01%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
EPS Next 5YN/A
Revenue Next Year-3.06%
Revenue Next 2Y-0.12%
Revenue Next 3Y3.2%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCHA.OL Yearly Revenue VS EstimatesSCHA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
SCHA.OL Yearly EPS VS EstimatesSCHA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 -20

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.01 indicates a rather expensive valuation of SCHA.
SCHA's Price/Earnings is on the same level as the industry average.
SCHA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
SCHA is valuated quite expensively with a Price/Forward Earnings ratio of 47.73.
SCHA's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, SCHA is valued quite expensively.
Industry RankSector Rank
PE 18.01
Fwd PE 47.73
SCHA.OL Price Earnings VS Forward Price EarningsSCHA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCHA indicates a slightly more expensive valuation: SCHA is more expensive than 70.59% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SCHA is valued a bit more expensive than the industry average as 69.12% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 119.06
EV/EBITDA 22.24
SCHA.OL Per share dataSCHA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

SCHA has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as SCHA's earnings are expected to decrease with -26.48% in the coming years.
PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.66%, SCHA is not a good candidate for dividend investing.
SCHA's Dividend Yield is comparable with the industry average which is at 6.05.
Compared to an average S&P500 Dividend Yield of 2.38, SCHA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

The dividend of SCHA is nicely growing with an annual growth rate of 113.59%!
Dividend Growth(5Y)113.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

SCHA pays out 157.84% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of SCHA has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP157.84%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
SCHA.OL Yearly Income VS Free CF VS DividendSCHA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B
SCHA.OL Dividend Payout.SCHA.OL Dividend Payout, showing the Payout Ratio.SCHA.OL Dividend Payout.PayoutRetained Earnings

SCHIBSTED ASA-CL A

OSL:SCHA (5/12/2025, 4:19:51 PM)

340

+1.4 (+0.41%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-18 2025-07-18
Inst Owners84.23%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap79.53B
Analysts71.3
Price Target354.53 (4.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend89.76
Dividend Growth(5Y)113.59%
DP157.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1016.78%
Min EPS beat(2)545.98%
Max EPS beat(2)1487.57%
EPS beat(4)2
Avg EPS beat(4)375.92%
Min EPS beat(4)-514.8%
Max EPS beat(4)1487.57%
EPS beat(8)3
Avg EPS beat(8)55.15%
EPS beat(12)3
Avg EPS beat(12)7.91%
EPS beat(16)4
Avg EPS beat(16)-1.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-2.05%
Max Revenue beat(2)1.72%
Revenue beat(4)2
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)7.24%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)5
Avg Revenue beat(12)-1.76%
Revenue beat(16)7
Avg Revenue beat(16)-1.46%
PT rev (1m)-5.39%
PT rev (3m)-8.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.15%
Valuation
Industry RankSector Rank
PE 18.01
Fwd PE 47.73
P/S 9.55
P/FCF 119.06
P/OCF 55.23
P/B 2.45
P/tB 3.22
EV/EBITDA 22.24
EPS(TTM)18.88
EY5.55%
EPS(NY)7.12
Fwd EY2.09%
FCF(TTM)2.86
FCFY0.84%
OCF(TTM)6.16
OCFY1.81%
SpS35.59
BVpS138.87
TBVpS105.57
PEG (NY)N/A
PEG (5Y)0.53
Profitability
Industry RankSector Rank
ROA 32.31%
ROE 39.89%
ROCE 2.71%
ROIC 2.09%
ROICexc 2.45%
ROICexgc 3.24%
OM 12.17%
PM (TTM) 155.64%
GM 111.9%
FCFM 8.02%
ROA(3y)1.92%
ROA(5y)14.39%
ROE(3y)-1.98%
ROE(5y)16.93%
ROIC(3y)2.06%
ROIC(5y)2.64%
ROICexc(3y)2.28%
ROICexc(5y)2.84%
ROICexgc(3y)3.08%
ROICexgc(5y)3.81%
ROCE(3y)2.73%
ROCE(5y)3.46%
ROICexcg growth 3Y1.98%
ROICexcg growth 5Y-40.51%
ROICexc growth 3Y-1.35%
ROICexc growth 5Y-24.02%
OM growth 3Y-1.54%
OM growth 5Y-3.72%
PM growth 3Y-18.04%
PM growth 5Y99.1%
GM growth 3Y-1.25%
GM growth 5Y-1.05%
F-Score7
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 5.81
Debt/EBITDA 1.07
Cap/Depr 31.02%
Cap/Sales 9.27%
Interest Coverage 3.34
Cash Conversion 41.12%
Profit Quality 5.16%
Current Ratio 3.04
Quick Ratio 3.04
Altman-Z N/A
F-Score7
WACC8.22%
ROIC/WACC0.25
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.96%
Cap/Sales(5y)8.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)365.92%
EPS 3Y75.21%
EPS 5Y33.81%
EPS Q2Q%-120.87%
EPS Next Y-81.01%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
EPS Next 5YN/A
Revenue 1Y (TTM)9.29%
Revenue growth 3Y-17.12%
Revenue growth 5Y-15.28%
Sales Q2Q%-46.89%
Revenue Next Year-3.06%
Revenue Next 2Y-0.12%
Revenue Next 3Y3.2%
Revenue Next 5YN/A
EBIT growth 1Y-22.26%
EBIT growth 3Y-18.4%
EBIT growth 5Y-18.43%
EBIT Next Year113.35%
EBIT Next 3Y48.65%
EBIT Next 5YN/A
FCF growth 1Y1.06%
FCF growth 3Y-24.42%
FCF growth 5Y-19.17%
OCF growth 1Y-15.69%
OCF growth 3Y-16.77%
OCF growth 5Y-12.73%